Dermatology

Taro Completes Acquisition of Alchemee

Retrieved on: 
Monday, February 28, 2022
General Health, Health, Cosmetics, Retail, Pharmaceutical, Industry, TPC, Growth, Taro, Omnichannel, Dermatology, NYSE, Acquisition, Acne, Marketing, Â, Risk management, Proactiv, Galderma

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro) today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma.

Key Points: 
  • Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro) today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma.
  • This acquisition demonstrates Taros commitment to strengthening our position in the over-the-counter dermatology space, said Uday Baldota, Taros CEO.
  • We are excited for Alchemee and its marquee brand, Proactiv, to join the expansive Taro portfolio of prescription and over-the-counter dermatology products, said Shannon Pappas, Global Head of Alchemee.
  • Neither Taro nor Alchemee has any obligation to publicly update or revise any forward-looking statements.

Australia Hair Removal Industry Analytics 2022-2027 by Product Type, End-user, Gender and Region - ResearchAndMarkets.com

Retrieved on: 
Monday, February 28, 2022
Cosmetics, Retail, IPL, Hair removal, Awareness, Woman, COVID-19, Population, Dermatology, CAGR, Urbanization, Social media, Male, Prevalence, Growth

The "Australia Hair Removal Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Australia Hair Removal Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The Australia hair removal market reached a value of US$ 806.5 million in 2021.
  • The rising consumer consciousness towards physical appearances is primarily driving the hair removal market in Australia.
  • Apart from this, several product manufacturers are launching convenient and easy-to-use automated hair removal products, such as epilators, trimmers, electric razors, etc.

Needle-Free Injection System Market by Technology, Product, Type of Medication, Application, End-users - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 25, 2022
Medical Supplies, Medical Devices, Health, Infectious Diseases, Diabetes, Biotechnology, Hospital, Clifton Springs Hospital & Clinic, Skin, Conditional sentence, Pain management, Technology, Dermatology, Biotechnology, CAGR, USD, Growth, Vaccination, Capillary, Infection, Prevalence, Pet, Diesel fuel, Vaccine, Healthcare

Fillable needle-free injectors segment accounted for the largest share in the needle-free injection system market.

Key Points: 
  • Fillable needle-free injectors segment accounted for the largest share in the needle-free injection system market.
  • In 2020, the fillable needle-free injectors accounted for the larger share of 63.4% of the needle-free injection system market.
  • Jet-based needle-free injectors segment accounted for the largest share in the needle-free injection system market.
  • Based on the type, the needle-free injection system market is segmented into liquid-based, powder-based and projectile/depot-based needle-free injectors.

SKINCEUTICALS ANNOUNCES OPENING OF SKINCEUTICALS SKINLAB™ IN PARTNERSHIP WITH BARBA SKIN CLINIC

Retrieved on: 
Monday, February 28, 2022
Partnership, Physician, Twitter, Antioxidant, Dermatology, Industry, Skin, Gold, Multimedia, Science, View, Laser, Maintenance, Patient, Skinlab, SkinCeuticals, Pharmaceutical industry, Cosmetics, Facebook, Instagram

MIAMI, Feb. 28, 2022 /PRNewswire/ -- SkinCeuticals, the #1 medical professional skincare brand in the US, announces the opening of the SkinCeuticals SkinLab by Barba Skin Clinic, located in the Coconut Grove community of Miami, Florida.

Key Points: 
  • MIAMI, Feb. 28, 2022 /PRNewswire/ -- SkinCeuticals, the #1 medical professional skincare brand in the US, announces the opening of the SkinCeuticals SkinLab by Barba Skin Clinic, located in the Coconut Grove community of Miami, Florida.
  • SkinCeuticals SkinLab by Barba Skin Clinic is an integrated skincare destination offering cutting edge, doctor-validated services with the ease and convenience that meets the demands of today's consumer.
  • At Barba Dermatology and at Barba Skin Clinic, our goal has always been to offer our patients a personalized and accessible approach to aesthetics."
  • Amy Sloan, Head of SkinCeuticals says, "The launch of SkinCeuticals SkinLab by Barba Skin Clinic is an incredibly exciting moment for us at SkinCeuticals.

Dr Ivan Puah Reveals That Using Calcium Hydroxyapatite Injection (Radiesse®️) Post Liposuction Can Improve Skin Laxity Significantly

Retrieved on: 
Thursday, February 24, 2022
Consensus, Hair, Abiathar, Elective surgery, Figueredo, Merz Aesthetics Women's Challenger, Cellulite, Use, Aesthetic Surgery Journal, Ministry, Merz, Buttocks, Leida Rammo, Yana, Honeycomb structure, Neck, Page, Collagen, Weight gain, Sports medicine, TCMB, Kate, Common, User experience, Medical director, Skin, Spa, Face, Lipo, Doctor of Philosophy, Lidocaine, Journal of Cosmetic Dermatology, FACS, Satō, Graduate diploma, FAAD, Allergan, DO, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine, Patient, Elastin, Injection, NUS, Bariatric surgery, Cosmetic, Commentary, NTU, Science, FDA, PMID, Time, Dietary supplement, Dentistry, Pharmaceutical industry, Perfume, Medical device, Abdomen, Acupuncture, Dermatology, Lorenc, Health, MD

With over 15 years of body contouring and liposuction experience, he has operated on many patients with excess body fat with pre-existing loose skin.

Key Points: 
  • With over 15 years of body contouring and liposuction experience, he has operated on many patients with excess body fat with pre-existing loose skin.
  • Dr. Puah has also co-conducted a study [8] on brachial laxity using the combination treatment of Ultherapy and Radiesse, with results demonstrating significant improvements in objective and subjective measures of brachial skin laxity.
  • MDC-Sculpt Lipo technique is a novel fat removal and body contouring technique that Dr. Ivan Puah has developed.
  • "Effectiveness of combined microfocused ultrasound with visualization and subdermal calcium hydroxyapatite injections for the management of brachial skin laxity."

Pasithea Therapeutics Announces Plans to Open Three New Clinics in the UK by Mid-2022

Retrieved on: 
Thursday, February 24, 2022
ZEN, GLOBE, Depression, Partnership, Anesthesia, Psychiatry, Nutritionist, Holborn, Lists of diseases, Psychosis, Therapy, Company, Pharmacy, Baker Street, Pharmacist, Transcranial magnetic stimulation, Post-traumatic stress disorder, KTTA, Food, Psychopharmacology, Private, MIAMI, Psychotherapy, Biotechnology, FDA, Anxiety, Nasdaq, Forward-looking statement, Patient, Ketamine, Dermatology, CEO, Research, Food and Drug Administration, SEC, Pharmaceutical industry, Pasithea (Charites)

MIAMI BEACH, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that its wholly owned subsidiary, Pasithea Clinics, has expanded its treatment offerings and is planning to open three new clinics in London to treat patients suffering from mental health issues. The Company already has locations in Marylebone and Knightsbridge.

Key Points: 
  • In addition to pharmacy services, our London clinics will offer other psychiatric treatment therapies, including repeated transcranial magnetic stimulation and ketamine and esketamine treatment, stated Dr. Tiago Reis Marques, CEO of Pasithea Therapeutics.
  • We are excited to expand our partnership with ZEN Healthcare, which has been providing pioneering IV therapies in London for six years.
  • The clinics, which will be operated by Pasithea, with management support from ZEN Healthcare, are expected to open by mid-2022.
  • Pasithea Therapeutics Corporation is a U.S. biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.

Verrica Pharmaceuticals Announces Participation in the 42nd Annual Cowen Virtual Healthcare Conference

Retrieved on: 
Thursday, February 24, 2022
GLOBE, Skin, Therapy, Webcast, Wart, Dermatology, Company, Molluscum contagiosum, Conference, CEO, Pharmaceutical industry, Broadcasting

WEST CHESTER, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the 42nd Annual Cowen Virtual Healthcare Conference on Wednesday, March 9, 2022, at 11:10 a.m.

Key Points: 
  • WEST CHESTER, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will participate in a fireside chat at the 42nd Annual Cowen Virtual Healthcare Conference on Wednesday, March 9, 2022, at 11:10 a.m.
  • Participants may access a live webcast of the event through the following link:
    The webcast can also be accessed in the Investors/Presentations & Events section of the Verrica website at www.verrica.com .
  • Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions.
  • Verrica is also developingVP-103,its second cantharidin-based product candidate, for the treatment of plantar warts.

Gold Series from Pantene Launches New Lengths Collection through a Dynamic Partnership with Ethel’s Club

Retrieved on: 
Thursday, February 24, 2022
Women, Consumer, Cosmetics, Retail, Specialty, Color, Partnership, Scetlander, Growth, Gold, Procter & Gamble, P&G, Ambi, Collection, Elasticity, Gold Series Vol.1, Woman, Education, Multimedia, News, Hair, EST, Dermatology, CEO, Cosmetics, Video game, Pharmaceutical industry, Black

The launch will culminate with a celebratory partnership with Ethels Club , a Black women-owned immersive wellness platform and social club for people of color.

Key Points: 
  • The launch will culminate with a celebratory partnership with Ethels Club , a Black women-owned immersive wellness platform and social club for people of color.
  • Together, Gold Series and Ethels Club will create enriching content and experiences for communities of color to embrace and take pride in their growth.
  • View the full release here: https://www.businesswire.com/news/home/20220224005616/en/
    Gold Series from Pantene Launches New Lengths Collection through a Dynamic Partnership with Ethels Club (Photo: Business Wire)
    Longer, stronger hair is a popular hair goal, said Ashley Taylor, Ph.D., Gold Series Scientist.
  • The Gold Series New Lengths Collection was designed to be a partner in her hair journey.

Medical Aesthetic Devices: Technologies and Global Markets, 2018-2021 & 2022-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 24, 2022
Medical Devices, Health, Risk, Health, Merz Pharma, Industry, Organization, Johnson & Johnson, Geography, AbbVie, Laser, Patient, Dermatology, Porter's five forces analysis, Bausch Health, Hospital, Medical device, Medical imaging, Risk management, Fine chemical

The "Medical Aesthetic Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Aesthetic Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report on medical aesthetic devices gives a detailed analysis of the devices used for medical aesthetic procedures.
  • The market landscape is also captured by end-user segments such as hospitals, beauty clinics and medical spas.
  • The report covers the current regulations and guidelines for medical device quality management and manufacturing practices in the context of their use within the medical aesthetic devices industry.

DermTech Management to Present at Upcoming Investor Conferences

Retrieved on: 
Thursday, February 24, 2022
Biotechnology, General Health, Health, Oncology, NASDAQ, Inflammation, Oppenheimer, Genomics, Dermatology, Skin, Medicine, Cowen, Medical imaging

DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that its management will present at the following upcoming conferences:

Key Points: 
  • DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that its management will present at the following upcoming conferences:
    Interested parties may access the live webcasts of the presentations and, for 90 days following the Cowen and Oppenheimer conferences, the archived webcasts of the presentations through the Investor Relations section of DermTechs website at: www.DermTech.com .
  • DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by our non-invasive skin genomics platform.
  • DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel.
  • For additional information on DermTech, please visit DermTech's investor relations site at: www.dermtech.com .